Scientific evidence collected over the past 4 decades suggests that a loss of cholinergic innervation in the cerebral cortex of patients with Alzheimer’s disease is an early pathogenic event correlated with cognitive impairment. This evidence led to the formulation of… Continue Reading →

Along with advanced age and apolipoprotein E (APOE)-4 genotype, female sex is a major risk factor for developing late-onset Alzheimer’s Disease (AD). Considering that AD pathology begins decades prior to clinical symptoms, the higher risk in women cannot simply be… Continue Reading →